RBC Europe’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3
Closed -$7K 625
2022
Q1
$7K Buy
+3
New +$7K ﹤0.01% 551
2021
Q4
Sell
-3
Closed -$20.3K 675
2021
Q3
$20.3K Hold
3
﹤0.01% 781
2021
Q2
$30.4K Hold
3
﹤0.01% 710
2021
Q1
$28.1K Buy
+3
New +$28.1K ﹤0.01% 679